Page last updated: 2024-08-16

moxonidine and eprosartan

moxonidine has been researched along with eprosartan in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Gurevich, MA1
Blankestijn, PJ; Koomans, HA; Ligtenberg, G; Neumann, J; Oey, L1
Calderone, A; Gillis, MA; Gutkowska, J; Jankowski, M; Menaouar, A; Mukaddam-Daher, S; Paquette, PA; Shi, YF; Tardif, JC1

Reviews

1 review(s) available for moxonidine and eprosartan

ArticleYear
[Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
    Klinicheskaia meditsina, 2002, Volume: 80, Issue:9

    Topics: Acrylates; Adrenergic alpha-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Doxazosin; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Perindopril; Risk Factors; Sex Factors; Sodium Chloride Symporter Inhibitors; Thiophenes

2002

Trials

1 trial(s) available for moxonidine and eprosartan

ArticleYear
Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.
    Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:11

    Topics: Acrylates; Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Muscle, Skeletal; Sympathetic Nervous System; Sympatholytics; Thiophenes

2004

Other Studies

4 other study(ies) available for moxonidine and eprosartan

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:5

    Topics: Acrylates; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Heart Rate; Hypertension; Imidazoles; Male; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Inbred SHR; Stroke; Thiophenes; Ventricular Function, Left

2009